The Claim
The combination of phenformin and dichloroacetate reduces hypoxia and HIF-1α expression in DIPG neurospheres and monolayer cultures.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Phenformin and dichloroacetate together lower oxygen deprivation and HIF-1α protein levels in laboratory-grown DIPG brain tumor cells.
See the scientific wording
The combination of phenformin and dichloroacetate reduces hypoxia and HIF-1α expression in DIPG neurospheres and monolayer cultures, suggesting that dual metabolic inhibition may alleviate tumor hypoxia—a known cause of radioresistance.
Two drugs together block both major ways tumor cells make energy, causing a severe energy shortage. This forces the cells to consume less oxygen, which increases oxygen levels inside the tumor. With more oxygen available, a protein that helps tumors survive low-oxygen conditions breaks down. Without this protein, the tumor cells cannot adapt to stress and become more vulnerable to damage.
What the research says
1 studyScientists found that using two drugs together—phenformin and dichloroacetate—made low-oxygen areas in brain tumor cells shrink and lowered a protein (HIF-1α) that helps tumors survive without oxygen. This happened in lab tests, which means the idea works in a dish.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.